Vetri Life Sciences Group

Molecule to Market as a service is a unique business model that covers stages covering elements from molecule discovery to the marketable product.

The Vetri Life Sciences Group companies help achieve that by providing necessary impetus at the right areas throughout the molecule to market journey.

The Vetri Life Sciences Group

Vetri Life Sciences

Ideation – Investment – Strategy – Global Program Management

About Vetri Life Sciences

Vetri Life Sciences develop transformative medicines for unmet medical needs under this model in an efficient and cost-effective manner using technology and data-driven approaches.

AstaLynx Global

Research and Development

About AstaLynx Global

AstaLynx Global is transforming the way Life Sciences organizations develop and bring new products to market. We leverage the latest technology advancements to reduce redundancies and improve process efficiencies for Pharmaceutical, Medical Device, Biotechnology, and Cosmetic companies.

Novolize

Global and Local Commercialization

About Novolize

Your complete commercialization expert and a complete and always reliable, high-performance commercialization and distribution engine.

Euclidata

Data Sciences and Technology

About Euclidata

Improve patient outcomes through reliable insights and better decision making

We drive better decision making and eliminate inefficiencies caused by siloed healthcare information that hold back innovation and improved patient care.